{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:56:46Z","timestamp":1793987806135,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Fondo de Investigaci\u00f3n Sanitario, Instituto de Salud Carlos III","award":["PI14\/1561"],"award-info":[{"award-number":["PI14\/1561"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0893-7","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T11:11:37Z","timestamp":1497006697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies"],"prefix":"10.1186","volume":"14","author":[{"given":"Marta","family":"Querol-Vilaseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00ed","family":"Colom-Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Pegueroles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"San Mart\u00edn-Paniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Clarimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Belbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"893_CR1","doi-asserted-by":"crossref","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358-72.","DOI":"10.1038\/nrn3880"},{"key":"893_CR2","doi-asserted-by":"crossref","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388-405.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"893_CR3","doi-asserted-by":"crossref","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines. Sci World J. 2012;2012:756357.","DOI":"10.1100\/2012\/756357"},{"key":"893_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"893_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"893_CR6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16:848\u201350.","journal-title":"Nat Neurosci"},{"key":"893_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016032","volume":"6","author":"RJ Perrin","year":"2011","unstructured":"Perrin RJ, Craig\u2010Schapiro R, Malone JP, et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer\u2019s disease. PLoS One. 2011;6, e16032.","journal-title":"PLoS One"},{"key":"893_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/bmm.12.42","volume":"6","author":"AM Fagan","year":"2012","unstructured":"Fagan AM, Perrin RJ. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. Biomark Med. 2012;6:455\u201376.","journal-title":"Biomark Med"},{"key":"893_CR9","doi-asserted-by":"crossref","unstructured":"Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol. 2013;4:122.","DOI":"10.3389\/fphys.2013.00122"},{"key":"893_CR10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","volume":"133","author":"M Comabella","year":"2010","unstructured":"Comabella M, Fernandez M, Martin R, et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain. 2010;133:1082\u201393.","journal-title":"Brain"},{"key":"893_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","volume":"42","author":"D Alcolea","year":"2014","unstructured":"Alcolea D, Carmona-Iragui M, Suarez-Calvet M, Sanchez-Saudinos MB, Sala I, Anton-Aguirre S. Relationship between \u00df-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:157\u201367.","journal-title":"J Alzheimers Dis"},{"key":"893_CR12","doi-asserted-by":"crossref","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):903\u201312.","DOI":"10.1016\/j.biopsych.2010.08.025"},{"key":"893_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","volume":"85","author":"D Alcolea","year":"2015","unstructured":"Alcolea D, Mart\u00ednez-Lage P, S\u00e1nchez-Juan P, Olazar\u00e1n J, Ant\u00fanez C, Izagirre A, Ecay-Torres M, Estanga A, Clerigu\u00e9 M, Guisasola MC, S\u00e1nchez Ruiz D, Mar\u00edn Mu\u00f1oz J, Calero M, et al. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology. 2015;85:626\u201333.","journal-title":"Neurology"},{"key":"893_CR14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","volume":"42","author":"A Antonell","year":"2014","unstructured":"Antonell A, Mansilla A, Rami L, Llad\u00f3 A, Iranzo A, Olives J, Balasa M, S\u00e1nchez-Valle R, Molinuevo JL. Cerebrospinal fluid Level of YKL-40 protein in preclinical and prodromal Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2014;42:901\u20138.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"893_CR15","doi-asserted-by":"crossref","unstructured":"Teunissen CE, Elias N, Koel-Simmelink MJA, et al. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst). 2016;2:86\u201394.","DOI":"10.1016\/j.dadm.2015.12.004"},{"key":"893_CR16","doi-asserted-by":"crossref","unstructured":"Alcolea D, Vilaplana E, Suarez-Calvet M, Ill\u00e1n-Gala I, Blesa R, Clarim\u00f3n J, et al. Cerebrospinal fluid sAPP\u03b2, YKL-40 and neurofilament light in frontotemporal lobar degeneration. Neurology. 2017 (in press).","DOI":"10.1212\/WNL.0000000000004088"},{"key":"893_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jns.2016.08.029","volume":"369","author":"C Sanfilippo","year":"2016","unstructured":"Sanfilippo C, Malaguarnera L, Di Rosa M. Chitinase expression in Alzheimer\u2019s disease and non-demented brains regions. J Neurol Sci. 2016;369:242\u20139.","journal-title":"J Neurol Sci"},{"key":"893_CR18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/neu.2010.1310","volume":"27","author":"D Bonneh\u2010Barkay","year":"2010","unstructured":"Bonneh\u2010Barkay D, Zagadailov P, Zou H, et al. YKL\u201040 expression in traumatic brain injury: an initial analysis. J Neurotrauma. 2010;27:1215\u201323.","journal-title":"J Neurotrauma"},{"key":"893_CR19","doi-asserted-by":"crossref","unstructured":"Cant\u00f3 E, Tintor\u00e9 M, Villar LM, Costa C, Nurtdinov R, \u00c1lvarez-Cerme\u00f1o JC, Arrambide G, Reverter F, Deisenhammer F, Hegen H, Khademi M, Olsson T, Tumani H, Rodr\u00edguez-Mart\u00edn E, et al. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain. 2015;138:918\u201331.","DOI":"10.1093\/brain\/awv017"},{"key":"893_CR20","doi-asserted-by":"crossref","unstructured":"Hinsinger G, Gal\u00e9otti N, Nabholz N, Urbach S, Rigau V, Demattei C, Lehmann S, Camu W, Labauge P, Castelnovo G, et al. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult Scler. 2015;21:1251\u201361.","DOI":"10.1177\/1352458514561906"},{"key":"893_CR21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","volume":"22","author":"D Bonneh-Barkay","year":"2012","unstructured":"Bonneh-Barkay D, Bissel SJ, Kofler J, Starkey A, Wang G, Wiley CA. Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol. 2012;22:530\u201346.","journal-title":"Brain Pathol"},{"key":"893_CR22","doi-asserted-by":"crossref","unstructured":"Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Mansson JE, Johansson JO, Olsson B, Wallin A, Svensson J, et al. Cerebrospinal fluid microglial markers in Alzheimer\u2019s disease: elevated chitotriosidase activity but lack of diagnostic utility. Neuromolecular Med. 2011;13(2):151\u20139.\u00a0","DOI":"10.1007\/s12017-011-8147-9"},{"key":"893_CR23","doi-asserted-by":"crossref","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Mart\u00ed MJ, Clarim\u00f3n J, Lle\u00f3 A. Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol. 2013;72:1203\u201312.","DOI":"10.1097\/NEN.0000000000000018"},{"key":"893_CR24","doi-asserted-by":"crossref","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","DOI":"10.1007\/s00401-011-0910-3"},{"key":"893_CR25","doi-asserted-by":"crossref","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","DOI":"10.1007\/s00401-006-0127-z"},{"key":"893_CR26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.jnen.0000229986.17548.27","volume":"65","author":"I Alafuzoff","year":"2006","unstructured":"Alafuzoff I, Pikkarainen M, Al-Sarraj S, et al. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol. 2006;65:740\u201357.","journal-title":"J Neuropathol Exp Neurol"},{"key":"893_CR27","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791\u2013800.","journal-title":"Neurology"},{"key":"893_CR28","doi-asserted-by":"crossref","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","DOI":"10.1038\/nmeth.2019"},{"key":"893_CR29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","volume":"169","author":"EMM Manders","year":"1993","unstructured":"Manders EMM, Verbeek FJ, Aten JA. Measurement of colocalization of objects in dual-colour confocal images. J Microscopy. 1993;169:375\u201382.","journal-title":"J Microscopy"},{"key":"893_CR30","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300:C723\u201342.","journal-title":"Am J Physiol Cell Physiol"},{"key":"893_CR31","doi-asserted-by":"crossref","unstructured":"Irwin DJ, Byrne MD, McMillan CT, Cooper F, Arnold SE, Lee EB, Van Deerlin VM, Xie SX, Lee VM, Grossman M, Trojanowski JQ. Semi-automated digital image analysis of Pick\u2019s disease and TDP-43 proteinopathy. J Histochem Cytochem. 2016;64(1):54\u201366.","DOI":"10.1369\/0022155415614303"},{"key":"893_CR32","doi-asserted-by":"crossref","unstructured":"Kovacs GG. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41:3\u201323.","DOI":"10.1111\/nan.12208"},{"key":"893_CR33","doi-asserted-by":"crossref","unstructured":"Hellwig K, Kvartsberg H, Portelius E, Andreasson U, Oberstein TJ, Lewczuk P, Blennow K, Kornhuber J, Maler JM, Zetterberg H, Spitzer P. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer\u2019s disease. Alzheimers Res Ther. 2015;7(1):74.","DOI":"10.1186\/s13195-015-0161-y"},{"key":"893_CR34","doi-asserted-by":"crossref","unstructured":"Lautner R, Mattsson N, Sch\u00f6ll M, Augutis K, Blennow K, Olsson B, Zetterberg H. Biomarkers for microglial activation in Alzheimer\u2019s disease. Int J Alzheimers Dis. 2011;2011:939426.","DOI":"10.4061\/2011\/939426"},{"key":"893_CR35","doi-asserted-by":"crossref","unstructured":"Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 2010;7:34.","DOI":"10.1186\/1742-2094-7-34"},{"key":"893_CR36","doi-asserted-by":"crossref","first-page":"19415","DOI":"10.1074\/jbc.271.32.19415","volume":"271","author":"B Hu","year":"1996","unstructured":"Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem. 1996;271:19415\u201320.","journal-title":"J Biol Chem"},{"key":"893_CR37","doi-asserted-by":"crossref","unstructured":"Nyirkos P, Golds EE. Human synovial-cells secrete a 39-kDa protein similar to a bovine mammary protein expressed during the nonlactating period. Biochem J. 1990;269:265\u20138.","DOI":"10.1042\/bj2690265"},{"key":"893_CR38","doi-asserted-by":"crossref","unstructured":"Shackelton LM, Mann DM, Millis AJ. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem. 1995;270:13076\u201383.","DOI":"10.1074\/jbc.270.22.13076"},{"key":"893_CR39","doi-asserted-by":"crossref","unstructured":"Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43:221\u20135.","DOI":"10.1006\/geno.1997.4778"},{"key":"893_CR40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/117727190700200023","volume":"2","author":"J Kzhyshkowska","year":"2007","unstructured":"Kzhyshkowska J, Gratchev A, Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights. 2007;2:128\u201346.","journal-title":"Biomark Insights"},{"key":"893_CR41","doi-asserted-by":"crossref","unstructured":"Shao R, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer. 2011;105(8):1203\u20139.","DOI":"10.1038\/bjc.2011.347"},{"key":"893_CR42","doi-asserted-by":"crossref","unstructured":"Lai T, Wu D, Chen M, Cao C, Jing Z, Huang L, Lv Y, Zhao X, Lv Q, Wang Y, Li D, Wu B, Shen H. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res. 2016;17:31.","DOI":"10.1186\/s12931-016-0338-3"},{"key":"893_CR43","doi-asserted-by":"crossref","first-page":"39893","DOI":"10.1074\/jbc.M111.257451","volume":"286","author":"SK Singh","year":"2011","unstructured":"Singh SK, Bhardwaj R, Wilczynska KM, Dumur CI, Kordula T. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40. J Biol Chem. 2011;286:39893\u2013903.","journal-title":"J Biol Chem"},{"key":"893_CR44","doi-asserted-by":"crossref","unstructured":"Br\u00f8chner CB, M\u00f8llg\u00e5rd K. SSEA\u20104 and YKL\u201040 positive progenitor subtypes in the subventricular zone of developing human neocortex. Glia. 2016;64(1):90\u2013104.","DOI":"10.1002\/glia.22905"},{"issue":"1","key":"893_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.266","volume":"3","author":"S Janelidze","year":"2015","unstructured":"Janelidze S, Hertze J, Zetterberg H, Landqvist Wald\u00f6 M, Santillo A, Blennow K, Hansson O. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2015;3(1):12\u201320.","journal-title":"Ann Clin Transl Neurol"},{"key":"893_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnagi.2013.00006","volume":"5","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Trojanowski JQ, Grossman M. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer\u2019s disease. Front Aging Neurosci. 2013;5:6.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"893_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000095638","volume":"3","author":"L Arnaud","year":"2006","unstructured":"Arnaud L, Robakis NK, Figueiredo E, Pereira ME. It may take inflammation, phosphorylation and ubiquitination to \u201ctangle\u201d in Alzheimer\u2019s disease. Neurodegener Dis. 2006;3(6):313\u20139.","journal-title":"Neurodegener Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:04:32Z","timestamp":1569431072000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0893-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0893-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]},"article-number":"118"}}